Looks like we’ve got another small cap company being touted by Nick Hodge for his Early Advantage service — but now, instead of the “blue blood” company that he’s been touting for a year or so as the potential enabler of a cancer cure, he’s pitching this “blue light” company as the one that will […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
This is a copy of my previous post regarding CRNT: Well, I committed to the unthinkable. I listened to the missed earni...
Right. We think similarly; I'm not expecting much until later in the year. However, positions are definitely being take...